nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—endothelium—malaria	0.0217	0.066	CbGeAlD
Dabigatran etexilate—F2—blood plasma—malaria	0.0192	0.0586	CbGeAlD
Dabigatran etexilate—UGT2B15—digestive system—malaria	0.0135	0.0411	CbGeAlD
Dabigatran etexilate—CES2—saliva-secreting gland—malaria	0.0124	0.0379	CbGeAlD
Dabigatran etexilate—UGT1A9—kidney—malaria	0.0121	0.0367	CbGeAlD
Dabigatran etexilate—CES2—hematopoietic system—malaria	0.0119	0.0361	CbGeAlD
Dabigatran etexilate—NQO2—saliva-secreting gland—malaria	0.0111	0.0338	CbGeAlD
Dabigatran etexilate—F2—hematopoietic system—malaria	0.0106	0.0324	CbGeAlD
Dabigatran etexilate—UGT1A9—digestive system—malaria	0.0102	0.0312	CbGeAlD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—DHFR—malaria	0.0101	0.076	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—liver—malaria	0.0101	0.0306	CbGeAlD
Dabigatran etexilate—CES1—hematopoietic system—malaria	0.00976	0.0298	CbGeAlD
Dabigatran etexilate—UGT2B7—kidney—malaria	0.00972	0.0296	CbGeAlD
Dabigatran etexilate—CES2—kidney—malaria	0.00972	0.0296	CbGeAlD
Dabigatran etexilate—Epigastric discomfort—Quinine—malaria	0.00909	0.0169	CcSEcCtD
Dabigatran etexilate—Epigastric discomfort—Quinidine—malaria	0.00909	0.0169	CcSEcCtD
Dabigatran etexilate—F2—kidney—malaria	0.00872	0.0266	CbGeAlD
Dabigatran etexilate—NQO2—kidney—malaria	0.00868	0.0265	CbGeAlD
Dabigatran etexilate—UGT2B7—digestive system—malaria	0.00824	0.0251	CbGeAlD
Dabigatran etexilate—CES2—digestive system—malaria	0.00824	0.0251	CbGeAlD
Dabigatran etexilate—Epigastric discomfort—Quinidine barbiturate—malaria	0.0082	0.0152	CcSEcCtD
Dabigatran etexilate—CES2—blood—malaria	0.00785	0.0239	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—malaria	0.00762	0.0232	CbGeAlD
Dabigatran etexilate—CES2—bone marrow—malaria	0.0076	0.0232	CbGeAlD
Dabigatran etexilate—F2—digestive system—malaria	0.00739	0.0225	CbGeAlD
Dabigatran etexilate—F2—blood—malaria	0.00704	0.0215	CbGeAlD
Dabigatran etexilate—NQO2—blood—malaria	0.00702	0.0214	CbGeAlD
Dabigatran etexilate—F2—bone marrow—malaria	0.00682	0.0208	CbGeAlD
Dabigatran etexilate—NQO2—bone marrow—malaria	0.00679	0.0207	CbGeAlD
Dabigatran etexilate—CES1—digestive system—malaria	0.00679	0.0207	CbGeAlD
Dabigatran etexilate—Haematuria—Pyrimethamine—malaria	0.00675	0.0125	CcSEcCtD
Dabigatran etexilate—CES1—blood—malaria	0.00647	0.0197	CbGeAlD
Dabigatran etexilate—CES2—liver—malaria	0.00614	0.0187	CbGeAlD
Dabigatran etexilate—UGT2B7—liver—malaria	0.00614	0.0187	CbGeAlD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—DHFR—malaria	0.00594	0.0448	CbGpPWpGaD
Dabigatran etexilate—F2—liver—malaria	0.00551	0.0168	CbGeAlD
Dabigatran etexilate—NQO2—liver—malaria	0.00549	0.0167	CbGeAlD
Dabigatran etexilate—CES2—E2F transcription factor network—DHFR—malaria	0.00534	0.0403	CbGpPWpGaD
Dabigatran etexilate—Bone disorder—Quinine—malaria	0.00529	0.00981	CcSEcCtD
Dabigatran etexilate—Bone disorder—Quinidine—malaria	0.00529	0.00981	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Proguanil—malaria	0.00521	0.00967	CcSEcCtD
Dabigatran etexilate—CES1—liver—malaria	0.00506	0.0154	CbGeAlD
Dabigatran etexilate—CES2—brain—malaria	0.00487	0.0149	CbGeAlD
Dabigatran etexilate—Bone disorder—Quinidine barbiturate—malaria	0.00478	0.00886	CcSEcCtD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.00461	0.0347	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—HBB—malaria	0.00459	0.0346	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Pyrimethamine—malaria	0.00451	0.00837	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Proguanil—malaria	0.00447	0.00829	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Proguanil—malaria	0.00446	0.00827	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Clindamycin—malaria	0.00445	0.00826	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Pyrimethamine—malaria	0.00442	0.0082	CcSEcCtD
Dabigatran etexilate—F2—brain—malaria	0.00437	0.0133	CbGeAlD
Dabigatran etexilate—Oesophagitis—Quinidine—malaria	0.00437	0.0081	CcSEcCtD
Dabigatran etexilate—Oesophagitis—Quinine—malaria	0.00437	0.0081	CcSEcCtD
Dabigatran etexilate—NQO2—brain—malaria	0.00435	0.0133	CbGeAlD
Dabigatran etexilate—CES2—NRF2 pathway—G6PD—malaria	0.00433	0.0327	CbGpPWpGaD
Dabigatran etexilate—Ecchymosis—Quinidine—malaria	0.00432	0.00801	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Quinine—malaria	0.00432	0.00801	CcSEcCtD
Dabigatran etexilate—Malnutrition—Proguanil—malaria	0.00431	0.00799	CcSEcCtD
Dabigatran etexilate—ABCB1—blood plasma—malaria	0.00414	0.0126	CbGeAlD
Dabigatran etexilate—CES1—brain—malaria	0.00401	0.0122	CbGeAlD
Dabigatran etexilate—Oesophagitis—Quinidine barbiturate—malaria	0.00394	0.00731	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Quinidine barbiturate—malaria	0.0039	0.00723	CcSEcCtD
Dabigatran etexilate—Cough—Proguanil—malaria	0.00376	0.00697	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—HBB—malaria	0.00374	0.0282	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Phase II conjugation—HPGDS—malaria	0.00368	0.0278	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—CR1—malaria	0.00364	0.0275	CbGpPWpGaD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00364	0.00676	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Proguanil—malaria	0.00345	0.00639	CcSEcCtD
Dabigatran etexilate—Skin disorder—Proguanil—malaria	0.00342	0.00633	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Pyrimethamine—malaria	0.00333	0.00617	CcSEcCtD
Dabigatran etexilate—Nasopharyngitis—Dapsone—malaria	0.00327	0.00606	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Clindamycin—malaria	0.00323	0.00599	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Quinidine—malaria	0.0032	0.00594	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Quinine—malaria	0.0032	0.00594	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Quinidine—malaria	0.00317	0.00588	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Quinine—malaria	0.00317	0.00588	CcSEcCtD
Dabigatran etexilate—Influenza—Dapsone—malaria	0.00316	0.00586	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL18—malaria	0.00315	0.0238	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—DHFR—malaria	0.00315	0.0237	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Proguanil—malaria	0.00304	0.00563	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—HBB—malaria	0.00297	0.0224	CbGpPWpGaD
Dabigatran etexilate—Bronchospasm—Quinidine—malaria	0.00295	0.00547	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Quinine—malaria	0.00295	0.00547	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Clindamycin—malaria	0.00293	0.00543	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Quinidine—malaria	0.00292	0.00542	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Quinine—malaria	0.00292	0.00542	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Quinidine barbiturate—malaria	0.00289	0.00536	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Proguanil—malaria	0.00288	0.00533	CcSEcCtD
Dabigatran etexilate—Vomiting—Pyrimethamine—malaria	0.00287	0.00532	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Quinidine barbiturate—malaria	0.00286	0.0053	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Clindamycin—malaria	0.00284	0.00527	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Proguanil—malaria	0.00278	0.00515	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Quinidine barbiturate—malaria	0.00266	0.00494	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Pentoxifylline—malaria	0.00266	0.00493	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Clindamycin—malaria	0.00265	0.00491	CcSEcCtD
Dabigatran etexilate—Sinusitis—Dapsone—malaria	0.00264	0.0049	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Quinidine barbiturate—malaria	0.00264	0.00489	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Pentoxifylline—malaria	0.00263	0.00488	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Pentoxifylline—malaria	0.00259	0.0048	CcSEcCtD
Dabigatran etexilate—Epistaxis—Clindamycin—malaria	0.00257	0.00477	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—SCARB1—malaria	0.00256	0.0193	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—G6PD—malaria	0.00255	0.0193	CbGpPWpGaD
Dabigatran etexilate—Arthralgia—Sulfadiazine—malaria	0.00243	0.00452	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—ICAM1—malaria	0.00243	0.0183	CbGpPWpGaD
Dabigatran etexilate—Haemoglobin—Quinidine—malaria	0.00241	0.00447	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Quinine—malaria	0.00241	0.00447	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Pentoxifylline—malaria	0.00241	0.00447	CcSEcCtD
Dabigatran etexilate—Infestation—Pentoxifylline—malaria	0.00241	0.00447	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Proguanil—malaria	0.00241	0.00446	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Quinidine—malaria	0.0024	0.00445	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Quinine—malaria	0.0024	0.00445	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Quinine—malaria	0.00237	0.0044	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Quinidine—malaria	0.00237	0.0044	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Quinidine—malaria	0.00235	0.00436	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Quinine—malaria	0.00235	0.00436	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Sulfadiazine—malaria	0.00233	0.00433	CcSEcCtD
Dabigatran etexilate—ABCB1—hematopoietic system—malaria	0.00229	0.00697	CbGeAlD
Dabigatran etexilate—Thrombocytopenia—Sulfadiazine—malaria	0.00229	0.00424	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Pentoxifylline—malaria	0.00228	0.00422	CcSEcCtD
Dabigatran etexilate—Epistaxis—Pentoxifylline—malaria	0.00227	0.00421	CcSEcCtD
Dabigatran etexilate—Vomiting—Proguanil—malaria	0.00224	0.00415	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Quinine—malaria	0.00223	0.00413	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Quinidine—malaria	0.00223	0.00413	CcSEcCtD
Dabigatran etexilate—Rash—Proguanil—malaria	0.00222	0.00411	CcSEcCtD
Dabigatran etexilate—Dermatitis—Proguanil—malaria	0.00221	0.00411	CcSEcCtD
Dabigatran etexilate—Headache—Proguanil—malaria	0.0022	0.00409	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Quinidine barbiturate—malaria	0.00218	0.00404	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Pentoxifylline—malaria	0.00217	0.00403	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Quinine—malaria	0.00217	0.00402	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Quinidine—malaria	0.00217	0.00402	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Quinidine barbiturate—malaria	0.00217	0.00402	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Quinine—malaria	0.00216	0.00401	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Quinidine—malaria	0.00216	0.00401	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Pentoxifylline—malaria	0.00216	0.00401	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—HPGDS—malaria	0.00215	0.0162	CbGpPWpGaD
Dabigatran etexilate—Urinary tract disorder—Quinidine barbiturate—malaria	0.00214	0.00397	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00213	0.00394	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Quinidine barbiturate—malaria	0.00212	0.00394	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—DHFR—malaria	0.0021	0.0158	CbGpPWpGaD
Dabigatran etexilate—Flatulence—Clindamycin—malaria	0.0021	0.00389	CcSEcCtD
Dabigatran etexilate—Malnutrition—Quinidine—malaria	0.00209	0.00387	CcSEcCtD
Dabigatran etexilate—Malnutrition—Quinine—malaria	0.00209	0.00387	CcSEcCtD
Dabigatran etexilate—Nausea—Proguanil—malaria	0.00209	0.00387	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—SCARB1—malaria	0.00208	0.0157	CbGpPWpGaD
Dabigatran etexilate—Back pain—Clindamycin—malaria	0.00206	0.00382	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Sulfadiazine—malaria	0.00202	0.00374	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Quinidine barbiturate—malaria	0.00201	0.00373	CcSEcCtD
Dabigatran etexilate—Anaemia—Clindamycin—malaria	0.00197	0.00365	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Quinidine barbiturate—malaria	0.00196	0.00363	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Pentoxifylline—malaria	0.00195	0.00362	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Quinidine barbiturate—malaria	0.00195	0.00362	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.00194	0.0146	CbGpPWpGaD
Dabigatran etexilate—Cough—Dapsone—malaria	0.00192	0.00356	CcSEcCtD
Dabigatran etexilate—Angioedema—Quinine—malaria	0.00191	0.00354	CcSEcCtD
Dabigatran etexilate—Angioedema—Quinidine—malaria	0.00191	0.00354	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Sulfadiazine—malaria	0.00191	0.00354	CcSEcCtD
Dabigatran etexilate—Malnutrition—Quinidine barbiturate—malaria	0.00189	0.0035	CcSEcCtD
Dabigatran etexilate—F2—Post-translational protein modification—NANP—malaria	0.00188	0.0142	CbGpPWpGaD
Dabigatran etexilate—ABCB1—kidney—malaria	0.00187	0.00571	CbGeAlD
Dabigatran etexilate—Syncope—Quinine—malaria	0.00187	0.00347	CcSEcCtD
Dabigatran etexilate—Syncope—Quinidine—malaria	0.00187	0.00347	CcSEcCtD
Dabigatran etexilate—Flatulence—Pentoxifylline—malaria	0.00185	0.00344	CcSEcCtD
Dabigatran etexilate—Urticaria—Sulfadiazine—malaria	0.00185	0.00344	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IFNG—malaria	0.00185	0.0139	CbGpPWpGaD
Dabigatran etexilate—Palpitations—Quinidine—malaria	0.00185	0.00342	CcSEcCtD
Dabigatran etexilate—Palpitations—Quinine—malaria	0.00185	0.00342	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Sulfadiazine—malaria	0.00185	0.00342	CcSEcCtD
Dabigatran etexilate—Hypertension—Clindamycin—malaria	0.00184	0.00341	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Quinine—malaria	0.00184	0.00341	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Quinidine—malaria	0.00184	0.00341	CcSEcCtD
Dabigatran etexilate—Back pain—Pentoxifylline—malaria	0.00182	0.00338	CcSEcCtD
Dabigatran etexilate—Chest pain—Quinine—malaria	0.00178	0.0033	CcSEcCtD
Dabigatran etexilate—Chest pain—Quinidine—malaria	0.00178	0.0033	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00177	0.00328	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00177	0.00328	CcSEcCtD
Dabigatran etexilate—Anaemia—Pentoxifylline—malaria	0.00174	0.00323	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Clindamycin—malaria	0.00174	0.00322	CcSEcCtD
Dabigatran etexilate—Angioedema—Quinidine barbiturate—malaria	0.00172	0.0032	CcSEcCtD
Dabigatran etexilate—Angioedema—Pentoxifylline—malaria	0.00172	0.00319	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Sulfadiazine—malaria	0.00172	0.00319	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Clindamycin—malaria	0.0017	0.00316	CcSEcCtD
Dabigatran etexilate—Syncope—Quinidine barbiturate—malaria	0.00169	0.00314	CcSEcCtD
Dabigatran etexilate—UGT2B7—Phase II conjugation—HPGDS—malaria	0.00168	0.0126	CbGpPWpGaD
Dabigatran etexilate—Shock—Quinidine—malaria	0.00168	0.00311	CcSEcCtD
Dabigatran etexilate—Shock—Quinine—malaria	0.00168	0.00311	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Quinidine—malaria	0.00167	0.0031	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Quinine—malaria	0.00167	0.0031	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Quinine—malaria	0.00167	0.0031	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Quinidine—malaria	0.00167	0.0031	CcSEcCtD
Dabigatran etexilate—Palpitations—Quinidine barbiturate—malaria	0.00167	0.00309	CcSEcCtD
Dabigatran etexilate—Palpitations—Pentoxifylline—malaria	0.00166	0.00308	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Quinidine barbiturate—malaria	0.00166	0.00307	CcSEcCtD
Dabigatran etexilate—Skin disorder—Quinine—malaria	0.00166	0.00307	CcSEcCtD
Dabigatran etexilate—Skin disorder—Quinidine—malaria	0.00166	0.00307	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—SCARB1—malaria	0.00165	0.0125	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Sulfadiazine—malaria	0.00165	0.00306	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL1B—malaria	0.00165	0.0124	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Pentoxifylline—malaria	0.00162	0.00301	CcSEcCtD
Dabigatran etexilate—Hypotension—Clindamycin—malaria	0.00162	0.00301	CcSEcCtD
Dabigatran etexilate—Chest pain—Quinidine barbiturate—malaria	0.00161	0.00298	CcSEcCtD
Dabigatran etexilate—Arthralgia—Quinidine barbiturate—malaria	0.00161	0.00298	CcSEcCtD
Dabigatran etexilate—Chest pain—Pentoxifylline—malaria	0.0016	0.00297	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Sulfadiazine—malaria	0.0016	0.00296	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00159	0.00296	CcSEcCtD
Dabigatran etexilate—Hypotension—Quinidine—malaria	0.00159	0.00295	CcSEcCtD
Dabigatran etexilate—Hypotension—Quinine—malaria	0.00159	0.00295	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00159	0.00295	CcSEcCtD
Dabigatran etexilate—ABCB1—digestive system—malaria	0.00159	0.00485	CbGeAlD
Dabigatran etexilate—Musculoskeletal discomfort—Quinine—malaria	0.00155	0.00288	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Quinidine—malaria	0.00155	0.00288	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Clindamycin—malaria	0.00155	0.00287	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Pentoxifylline—malaria	0.00154	0.00285	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Clindamycin—malaria	0.00153	0.00284	CcSEcCtD
Dabigatran etexilate—Infection—Pentoxifylline—malaria	0.00153	0.00283	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Quinidine—malaria	0.00152	0.00282	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Quinine—malaria	0.00152	0.00282	CcSEcCtD
Dabigatran etexilate—ABCB1—blood—malaria	0.00151	0.00462	CbGeAlD
Dabigatran etexilate—Shock—Quinidine barbiturate—malaria	0.00151	0.00281	CcSEcCtD
Dabigatran etexilate—Shock—Pentoxifylline—malaria	0.00151	0.0028	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Quinidine barbiturate—malaria	0.00151	0.0028	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—ACKR1—malaria	0.00151	0.0114	CbGpPWpGaD
Dabigatran etexilate—Thrombocytopenia—Quinidine barbiturate—malaria	0.00151	0.00279	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Pentoxifylline—malaria	0.0015	0.00279	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Clindamycin—malaria	0.0015	0.00278	CcSEcCtD
Dabigatran etexilate—Fatigue—Clindamycin—malaria	0.0015	0.00278	CcSEcCtD
Dabigatran etexilate—Skin disorder—Quinidine barbiturate—malaria	0.00149	0.00277	CcSEcCtD
Dabigatran etexilate—Skin disorder—Pentoxifylline—malaria	0.00149	0.00277	CcSEcCtD
Dabigatran etexilate—Constipation—Clindamycin—malaria	0.00149	0.00276	CcSEcCtD
Dabigatran etexilate—Vomiting—Sulfadiazine—malaria	0.00148	0.00275	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Quinidine—malaria	0.00147	0.00273	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Quinine—malaria	0.00147	0.00273	CcSEcCtD
Dabigatran etexilate—Rash—Sulfadiazine—malaria	0.00147	0.00273	CcSEcCtD
Dabigatran etexilate—Dermatitis—Sulfadiazine—malaria	0.00147	0.00273	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dapsone—malaria	0.00147	0.00272	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—G6PD—malaria	0.00147	0.0111	CbGpPWpGaD
Dabigatran etexilate—ABCB1—bone marrow—malaria	0.00147	0.00447	CbGeAlD
Dabigatran etexilate—Headache—Sulfadiazine—malaria	0.00146	0.00271	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CRP—malaria	0.00145	0.0109	CbGpPWpGaD
Dabigatran etexilate—Hypotension—Quinidine barbiturate—malaria	0.00144	0.00267	CcSEcCtD
Dabigatran etexilate—Hypotension—Pentoxifylline—malaria	0.00144	0.00266	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Clindamycin—malaria	0.00142	0.00264	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dapsone—malaria	0.00142	0.00263	CcSEcCtD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.0014	0.0106	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.0014	0.0026	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Pentoxifylline—malaria	0.0014	0.0026	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Quinidine—malaria	0.00139	0.00259	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Quinine—malaria	0.00139	0.00259	CcSEcCtD
Dabigatran etexilate—Nausea—Sulfadiazine—malaria	0.00139	0.00257	CcSEcCtD
Dabigatran etexilate—Urticaria—Clindamycin—malaria	0.00138	0.00256	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Clindamycin—malaria	0.00137	0.00255	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Quinidine barbiturate—malaria	0.00137	0.00254	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Pentoxifylline—malaria	0.00137	0.00254	CcSEcCtD
Dabigatran etexilate—UGT1A9—Phase II conjugation—HPGDS—malaria	0.00136	0.0103	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL4—malaria	0.00136	0.0103	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Quinine—malaria	0.00135	0.00251	CcSEcCtD
Dabigatran etexilate—Urticaria—Quinidine—malaria	0.00135	0.00251	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Pentoxifylline—malaria	0.00135	0.00251	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Quinidine—malaria	0.00135	0.0025	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Quinine—malaria	0.00135	0.0025	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—ICAM1—malaria	0.00133	0.01	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00133	0.00246	CcSEcCtD
Dabigatran etexilate—Constipation—Quinidine barbiturate—malaria	0.00132	0.00244	CcSEcCtD
Dabigatran etexilate—Constipation—Pentoxifylline—malaria	0.00131	0.00244	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Clindamycin—malaria	0.00128	0.00237	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00126	0.00233	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Quinidine—malaria	0.00126	0.00233	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Quinine—malaria	0.00126	0.00233	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Pentoxifylline—malaria	0.00126	0.00233	CcSEcCtD
Dabigatran etexilate—Asthenia—Clindamycin—malaria	0.00125	0.00231	CcSEcCtD
Dabigatran etexilate—Pruritus—Clindamycin—malaria	0.00123	0.00228	CcSEcCtD
Dabigatran etexilate—Asthenia—Quinidine—malaria	0.00122	0.00227	CcSEcCtD
Dabigatran etexilate—Asthenia—Quinine—malaria	0.00122	0.00227	CcSEcCtD
Dabigatran etexilate—Urticaria—Quinidine barbiturate—malaria	0.00122	0.00227	CcSEcCtD
Dabigatran etexilate—Urticaria—Pentoxifylline—malaria	0.00122	0.00226	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Quinidine barbiturate—malaria	0.00122	0.00226	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Pentoxifylline—malaria	0.00121	0.00225	CcSEcCtD
Dabigatran etexilate—Pruritus—Quinidine—malaria	0.00121	0.00224	CcSEcCtD
Dabigatran etexilate—Pruritus—Quinine—malaria	0.00121	0.00224	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—G6PD—malaria	0.00119	0.00899	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Clindamycin—malaria	0.00119	0.00221	CcSEcCtD
Dabigatran etexilate—ABCB1—liver—malaria	0.00118	0.00361	CbGeAlD
Dabigatran etexilate—F2—Folate Metabolism—CRP—malaria	0.00118	0.00887	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Quinidine—malaria	0.00117	0.00216	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Quinine—malaria	0.00117	0.00216	CcSEcCtD
Dabigatran etexilate—Dizziness—Clindamycin—malaria	0.00115	0.00213	CcSEcCtD
Dabigatran etexilate—Vomiting—Dapsone—malaria	0.00114	0.00212	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Quinidine barbiturate—malaria	0.00113	0.0021	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Pentoxifylline—malaria	0.00113	0.0021	CcSEcCtD
Dabigatran etexilate—Dizziness—Quinidine—malaria	0.00113	0.00209	CcSEcCtD
Dabigatran etexilate—Dizziness—Quinine—malaria	0.00113	0.00209	CcSEcCtD
Dabigatran etexilate—Headache—Dapsone—malaria	0.00113	0.00209	CcSEcCtD
Dabigatran etexilate—Vomiting—Clindamycin—malaria	0.00111	0.00205	CcSEcCtD
Dabigatran etexilate—Asthenia—Quinidine barbiturate—malaria	0.0011	0.00205	CcSEcCtD
Dabigatran etexilate—Asthenia—Pentoxifylline—malaria	0.0011	0.00204	CcSEcCtD
Dabigatran etexilate—Rash—Clindamycin—malaria	0.0011	0.00203	CcSEcCtD
Dabigatran etexilate—Dermatitis—Clindamycin—malaria	0.00109	0.00203	CcSEcCtD
Dabigatran etexilate—Headache—Clindamycin—malaria	0.00109	0.00202	CcSEcCtD
Dabigatran etexilate—Pruritus—Quinidine barbiturate—malaria	0.00109	0.00202	CcSEcCtD
Dabigatran etexilate—Pruritus—Pentoxifylline—malaria	0.00109	0.00202	CcSEcCtD
Dabigatran etexilate—Vomiting—Quinine—malaria	0.00108	0.00201	CcSEcCtD
Dabigatran etexilate—Vomiting—Quinidine—malaria	0.00108	0.00201	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—ICAM1—malaria	0.00108	0.00815	CbGpPWpGaD
Dabigatran etexilate—Rash—Quinidine—malaria	0.00108	0.00199	CcSEcCtD
Dabigatran etexilate—Rash—Quinine—malaria	0.00108	0.00199	CcSEcCtD
Dabigatran etexilate—Dermatitis—Quinidine—malaria	0.00107	0.00199	CcSEcCtD
Dabigatran etexilate—Dermatitis—Quinine—malaria	0.00107	0.00199	CcSEcCtD
Dabigatran etexilate—Headache—Quinidine—malaria	0.00107	0.00198	CcSEcCtD
Dabigatran etexilate—Headache—Quinine—malaria	0.00107	0.00198	CcSEcCtD
Dabigatran etexilate—Nausea—Dapsone—malaria	0.00107	0.00198	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Quinidine barbiturate—malaria	0.00105	0.00195	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Pentoxifylline—malaria	0.00105	0.00195	CcSEcCtD
Dabigatran etexilate—Nausea—Clindamycin—malaria	0.00103	0.00191	CcSEcCtD
Dabigatran etexilate—Dizziness—Quinidine barbiturate—malaria	0.00102	0.00189	CcSEcCtD
Dabigatran etexilate—Dizziness—Pentoxifylline—malaria	0.00102	0.00188	CcSEcCtD
Dabigatran etexilate—Nausea—Quinidine—malaria	0.00101	0.00188	CcSEcCtD
Dabigatran etexilate—Nausea—Quinine—malaria	0.00101	0.00188	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.00101	0.00763	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IFNG—malaria	0.00101	0.00762	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—HPGDS—malaria	0.000981	0.0074	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Quinidine barbiturate—malaria	0.000978	0.00181	CcSEcCtD
Dabigatran etexilate—Vomiting—Pentoxifylline—malaria	0.000977	0.00181	CcSEcCtD
Dabigatran etexilate—Rash—Quinidine barbiturate—malaria	0.00097	0.0018	CcSEcCtD
Dabigatran etexilate—Dermatitis—Quinidine barbiturate—malaria	0.000969	0.0018	CcSEcCtD
Dabigatran etexilate—Rash—Pentoxifylline—malaria	0.000968	0.0018	CcSEcCtD
Dabigatran etexilate—Dermatitis—Pentoxifylline—malaria	0.000968	0.00179	CcSEcCtD
Dabigatran etexilate—Headache—Quinidine barbiturate—malaria	0.000964	0.00179	CcSEcCtD
Dabigatran etexilate—Headache—Pentoxifylline—malaria	0.000962	0.00178	CcSEcCtD
Dabigatran etexilate—ABCB1—brain—malaria	0.00094	0.00286	CbGeAlD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CRP—malaria	0.000934	0.00704	CbGpPWpGaD
Dabigatran etexilate—Nausea—Quinidine barbiturate—malaria	0.000914	0.0017	CcSEcCtD
Dabigatran etexilate—Nausea—Pentoxifylline—malaria	0.000912	0.00169	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL1B—malaria	0.000902	0.0068	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—NANP—malaria	0.000894	0.00674	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—ICAM1—malaria	0.000859	0.00647	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—DHODH—malaria	0.000841	0.00634	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000832	0.00627	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IFNG—malaria	0.000823	0.0062	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—HPGDS—malaria	0.000797	0.00601	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—ACKR1—malaria	0.00077	0.00581	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000742	0.0056	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000739	0.00557	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL1B—malaria	0.000734	0.00553	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—HBB—malaria	0.000733	0.00552	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL2—malaria	0.000731	0.00551	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC4A1—malaria	0.000715	0.00539	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—DECR1—malaria	0.000673	0.00507	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—malaria	0.000665	0.00501	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—CD36—malaria	0.000657	0.00495	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—TNF—malaria	0.000654	0.00493	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IFNG—malaria	0.000653	0.00493	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000643	0.00485	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—HBB—malaria	0.000608	0.00459	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL1B—malaria	0.000583	0.00439	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL12B—malaria	0.000576	0.00434	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000559	0.00421	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PKLR—malaria	0.000542	0.00409	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000539	0.00406	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TNF—malaria	0.000532	0.00401	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL6—malaria	0.000528	0.00398	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—CD36—malaria	0.000496	0.00374	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—G6PD—malaria	0.000483	0.00364	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.000443	0.00334	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL6—malaria	0.00043	0.00324	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—TNF—malaria	0.000423	0.00319	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CD40LG—malaria	0.000421	0.00318	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL10—malaria	0.000421	0.00318	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL4—malaria	0.00041	0.00309	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—HLA-B—malaria	0.000401	0.00302	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ACKR1—malaria	0.000395	0.00298	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DHODH—malaria	0.000383	0.00289	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—FAS—malaria	0.000378	0.00285	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	0.000373	0.00281	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—HPGDS—malaria	0.000368	0.00278	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—DHFR—malaria	0.000342	0.00258	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL6—malaria	0.000341	0.00257	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SCARB1—malaria	0.000338	0.00255	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000336	0.00254	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC4A1—malaria	0.000326	0.00246	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DHODH—malaria	0.000311	0.00235	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DECR1—malaria	0.000306	0.00231	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000306	0.00231	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000281	0.00212	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—IL2—malaria	0.000278	0.0021	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HBB—malaria	0.000277	0.00209	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC4A1—malaria	0.000265	0.002	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000259	0.00195	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CD36—malaria	0.000256	0.00193	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DECR1—malaria	0.000249	0.00188	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IFNG—malaria	0.000248	0.00187	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PKLR—malaria	0.000247	0.00186	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ACKR1—malaria	0.000234	0.00176	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HBB—malaria	0.000225	0.0017	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—malaria	0.000221	0.00167	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL2—malaria	0.00022	0.00166	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—G6PD—malaria	0.00022	0.00166	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CD36—malaria	0.000212	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—malaria	0.00021	0.00159	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PKLR—malaria	0.000201	0.00151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TLR9—malaria	0.000188	0.00142	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000186	0.0014	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—G6PD—malaria	0.000179	0.00135	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CD36—malaria	0.000176	0.00133	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HPGDS—malaria	0.000168	0.00127	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	0.000167	0.00126	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—malaria	0.00016	0.00121	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DHFR—malaria	0.000156	0.00117	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SCARB1—malaria	0.000154	0.00116	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IL2—malaria	0.000143	0.00108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DHODH—malaria	0.000143	0.00108	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HPGDS—malaria	0.000136	0.00103	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DHFR—malaria	0.000127	0.000954	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SCARB1—malaria	0.000125	0.000944	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC4A1—malaria	0.000121	0.000916	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DECR1—malaria	0.000114	0.000861	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HBB—malaria	0.000103	0.000779	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CD36—malaria	9.67e-05	0.000729	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PKLR—malaria	9.2e-05	0.000694	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL2—malaria	9.06e-05	0.000683	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL2—malaria	8.22e-05	0.00062	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—G6PD—malaria	8.2e-05	0.000618	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	7.91e-05	0.000596	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CD36—malaria	7.86e-05	0.000592	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KDR—malaria	7.49e-05	0.000565	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HPGDS—malaria	6.26e-05	0.000472	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DHFR—malaria	5.8e-05	0.000438	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SCARB1—malaria	5.74e-05	0.000433	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2—malaria	4.86e-05	0.000366	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—malaria	4.83e-05	0.000364	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CD36—malaria	3.6e-05	0.000272	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—malaria	2.86e-05	0.000215	CbGpPWpGaD
